|
STAT3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.743830E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.645200E-01 |
| Normal-vs-Stage2 |
6.895800E-02 |
| Normal-vs-Stage3 |
1.332570E-01 |
| Normal-vs-Stage4 |
8.371600E-02 |
| Stage1-vs-Stage2 |
1.892570E-01 |
| Stage1-vs-Stage3 |
4.101000E-01 |
| Stage1-vs-Stage4 |
2.696400E-01 |
| Stage2-vs-Stage3 |
4.983600E-01 |
| Stage2-vs-Stage4 |
6.554600E-01 |
| Stage3-vs-Stage4 |
7.989000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.559600E-01 |
| Normal-vs-AfricanAmerican |
9.046600E-01 |
| Normal-vs-Asian |
7.613000E-01 |
| Caucasian-vs-AfricanAmerican |
6.121800E-01 |
| Caucasian-vs-Asian |
6.153200E-01 |
| AfricanAmerican-vs-Asian |
9.120600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.352000E-02 |
| Normal-vs-Female |
3.361600E-01 |
| Male-vs-Female |
7.111900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.830200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.793230E-01 |
| Normal-vs-Age(61-80Yrs) |
1.026390E-02 |
| Normal-vs-Age(81-100Yrs) |
2.601600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.703600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.332330E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.389800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.257380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.385600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.303000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.923390E-01 |
| Classical-VS-Follicular |
4.71511718558304E-13 |
| Classical-VS-Other |
1.782370E-02 |
| Classical-VS-Normal |
8.014000E-01 |
| Tall-VS-Follicular |
8.840400E-04 |
| Tall-VS-Other |
5.680200E-02 |
| Tall-VS-Normal |
3.015200E-01 |
| Follicular-VS-Other |
9.729000E-01 |
| Follicular-VS-Normal |
2.78390000052475E-07 |
| Other-VS-Normal |
1.735950E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.034100E-02 |
| Normal-vs-N1 |
2.788400E-01 |
| N0-vs-N1 |
4.623400E-01 |
|
|
